 Vancouver, British Columbia--Newsfile Corp. - January 15, 2021 - Neovasc Inc. NASDAQ: NVCN TSX: NVCN Neovasc or the Company announced today that it has received a not-approvable letter from U.S. Food Drug Administration FDA regarding its PMA submission for the Neovasc ReducerTM Reducer.Fred Colen, Neovasc CEO, said, While we are disappointed in FDAs decision, the letter was not unexpected, given the outcome of the Panel meeting. He continued, Millions of patients suffer from refractory angina, and... 